India

Last Updated 17 September 2021.

7 Vaccines Approved for Use in India

• Zydus Cadila
  ZyCoV-D

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  5 trials in 1 country

  Approval Source: reuters.com

  DNA

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 72 countries

  26 trials in 6 countries

  Approval Source: france24.com

  RNA

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 71 countries

  21 trials in 7 countries

  Approval Source: pib.gov.in

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 64 countries

  11 trials in 17 countries

  Approval Source: reuters.com

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 121 countries

  40 trials in 21 countries

  Approval Source: nytimes.com

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 45 countries

  2 trials in 1 country

  Approval Source: cdsco.gov.in

  Non Replicating Viral Vector

• Bharat Biotech
  Covaxin

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 9 countries

  7 trials in 1 country

  Approval Source: bbc.com

  Inactivated

13 Vaccines in Clinical Trials in India

• Novavax
  NVX-CoV2373

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  10 trials in 7 countries

  Protein Subunit

• Serum Institute of India
  COVOVAX

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  2 trials in 1 country

  Protein Subunit

• Zydus Cadila
  ZyCoV-D

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  5 trials in 1 country

  DNA

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 71 countries

  21 trials in 7 countries

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 121 countries

  40 trials in 21 countries

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 45 countries

  2 trials in 1 country

  Non Replicating Viral Vector

• Bharat Biotech
  Covaxin

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 9 countries

  7 trials in 1 country

  Inactivated

• Biological E Limited
  BECOV2A

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  Protein Subunit

• Biological E Limited
  BECOV2B

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  Protein Subunit

• Biological E Limited
  BECOV2C

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  0 trials in 1 country

  Protein Subunit

• Biological E Limited
  BECOV2D

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  Protein Subunit

• Gennova Biopharmaceuticals Limited
  HGCO19

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  RNA

• Bharat Biotech
  BBV154

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Non Replicating Viral Vector